FDA Inspection 1256728 — Lally Mekokishvili
The FDA completed an inspection of Lally Mekokishvili on Nov 14, 2024 in Tbilisi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 14, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tbilisi (Georgia)
Additional Details
Clinical Investigator (CI)